DK139716B - Analogifremgangsmåde til fremstilling af 4-aminoamfetaminderivater. - Google Patents
Analogifremgangsmåde til fremstilling af 4-aminoamfetaminderivater.Info
- Publication number
- DK139716B DK139716B DK464774AA DK464774A DK139716B DK 139716 B DK139716 B DK 139716B DK 464774A A DK464774A A DK 464774AA DK 464774 A DK464774 A DK 464774A DK 139716 B DK139716 B DK 139716B
- Authority
- DK
- Denmark
- Prior art keywords
- aminoamphetamine
- derivatives
- preparation
- analogous process
- analogous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK4176A DK145571C (da) | 1973-09-04 | 1976-01-07 | Beta-nitrostyrenderivat til anvendelse som mellemprodukt ved fremstilling af 4-aminoamfetaminderivater |
| DK346981A DK146280C (da) | 1973-09-04 | 1981-08-04 | Fenylaetylaminderivater til anvendelse som mellemprodukter ved fremstilling af 4-aminoamfetaminderivater |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7312001A SE382047B (sv) | 1973-09-04 | 1973-09-04 | Forfarande for framstellning av 4-aminoamfetaminderivat |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK464774A DK464774A (fi) | 1975-05-05 |
| DK139716B true DK139716B (da) | 1979-04-02 |
| DK139716C DK139716C (fi) | 1979-09-17 |
Family
ID=20318423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK464774AA DK139716B (da) | 1973-09-04 | 1974-09-03 | Analogifremgangsmåde til fremstilling af 4-aminoamfetaminderivater. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3996381A (fi) |
| JP (1) | JPS5835177B2 (fi) |
| AT (1) | AT336566B (fi) |
| BE (1) | BE819515A (fi) |
| CA (1) | CA1051436A (fi) |
| CH (2) | CH603547A5 (fi) |
| DE (1) | DE2440734C2 (fi) |
| DK (1) | DK139716B (fi) |
| FI (1) | FI62281C (fi) |
| FR (1) | FR2242079B1 (fi) |
| GB (1) | GB1461667A (fi) |
| HK (1) | HK75778A (fi) |
| IE (1) | IE40514B1 (fi) |
| LU (1) | LU70852A1 (fi) |
| NL (1) | NL7411753A (fi) |
| NO (2) | NO139408C (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050059743A1 (en) * | 2000-11-01 | 2005-03-17 | Sention, Inc. | Methods for treating mild cognitive impairment and alzheimer's disease |
| US20030232890A1 (en) * | 2000-11-01 | 2003-12-18 | Sention, Inc. | Methods for treating an impairment in memory consolidation |
| TWI291871B (en) * | 2000-11-01 | 2008-01-01 | Cognition Pharmaceuticals Llc | Pharmaceutical compositions and use of amphetamine compounds for improving memory and learning |
| US20070117869A1 (en) * | 2000-11-01 | 2007-05-24 | Cognition Pharmaceuticals Llc | Methods for treating coginitive impairment and improving cognition |
| US7619005B2 (en) * | 2000-11-01 | 2009-11-17 | Cognition Pharmaceuticals Llc | Methods for treating cognitive impairment in humans with Multiple Sclerosis |
| US20030119884A1 (en) * | 2000-11-01 | 2003-06-26 | Epstein Mel H. | Methods and compositions for regulating memory consolidation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3117160A (en) * | 1961-07-27 | 1964-01-07 | Pfizer & Co C | Aralkylamines |
| US3496195A (en) * | 1966-05-11 | 1970-02-17 | Chinoin Gyogyszer Es Vegyeszet | D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts |
-
1974
- 1974-08-14 US US05/497,295 patent/US3996381A/en not_active Expired - Lifetime
- 1974-08-24 DE DE2440734A patent/DE2440734C2/de not_active Expired
- 1974-08-30 AT AT702574A patent/AT336566B/de not_active IP Right Cessation
- 1974-09-03 CH CH1173577A patent/CH603547A5/xx not_active IP Right Cessation
- 1974-09-03 CH CH1195874A patent/CH599106A5/xx not_active IP Right Cessation
- 1974-09-03 FR FR7429970A patent/FR2242079B1/fr not_active Expired
- 1974-09-03 CA CA208,356A patent/CA1051436A/en not_active Expired
- 1974-09-03 GB GB3849974A patent/GB1461667A/en not_active Expired
- 1974-09-03 JP JP49100618A patent/JPS5835177B2/ja not_active Expired
- 1974-09-03 IE IE1824/74A patent/IE40514B1/xx unknown
- 1974-09-03 DK DK464774AA patent/DK139716B/da not_active IP Right Cessation
- 1974-09-03 FI FI2576/74A patent/FI62281C/fi active
- 1974-09-04 NL NL7411753A patent/NL7411753A/xx not_active Application Discontinuation
- 1974-09-04 LU LU70852A patent/LU70852A1/xx unknown
- 1974-09-04 BE BE148180A patent/BE819515A/xx not_active IP Right Cessation
- 1974-09-04 NO NO743177A patent/NO139408C/no unknown
-
1978
- 1978-12-28 HK HK757/78A patent/HK75778A/xx unknown
-
1979
- 1979-05-04 NO NO791507A patent/NO142624C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5835177B2 (ja) | 1983-08-01 |
| FR2242079B1 (fi) | 1978-07-21 |
| FR2242079A1 (fi) | 1975-03-28 |
| ATA702574A (de) | 1976-09-15 |
| NO139408B (no) | 1978-11-27 |
| FI62281B (fi) | 1982-08-31 |
| IE40514L (en) | 1975-03-04 |
| CA1051436A (en) | 1979-03-27 |
| IE40514B1 (en) | 1979-06-20 |
| CH603547A5 (fi) | 1978-08-31 |
| NO743177L (fi) | 1975-04-01 |
| AU7283374A (en) | 1976-03-04 |
| NO139408C (no) | 1979-03-07 |
| AT336566B (de) | 1977-05-10 |
| DK139716C (fi) | 1979-09-17 |
| FI257674A (fi) | 1975-03-05 |
| GB1461667A (en) | 1977-01-19 |
| DE2440734A1 (de) | 1975-03-13 |
| CH599106A5 (fi) | 1978-05-12 |
| BE819515A (fr) | 1975-03-04 |
| NL7411753A (nl) | 1975-03-06 |
| JPS5050329A (fi) | 1975-05-06 |
| HK75778A (en) | 1979-01-05 |
| NO791507L (no) | 1975-03-05 |
| NO142624C (no) | 1980-09-17 |
| FI62281C (fi) | 1982-12-10 |
| LU70852A1 (fi) | 1975-06-11 |
| NO142624B (no) | 1980-06-09 |
| DE2440734C2 (de) | 1985-01-24 |
| DK464774A (fi) | 1975-05-05 |
| US3996381A (en) | 1976-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK137329B (da) | Analogifremgangsmåde til fremstilling af 2-karbalkoksyaminobenzimidazolderivater. | |
| DK134345B (da) | Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater. | |
| DK135376B (da) | Fremgangsmåde til fremstilling af piperazinylquinazolin-forbindelser. | |
| DK137835B (da) | Analogifremgangsmåde til fremstilling af thienothiazinderivater. | |
| DK140484B (da) | Fremgangsmåde til fremstilling af zeaxanthin. | |
| DK134031B (da) | Fremgangsmåde til fremstilling af et endo-beta-glucanase-præparat. | |
| DK135766B (da) | Analogifremgangsmåde til fremstilling af isoquinoliner. | |
| DK137389B (da) | Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener. | |
| DK138759B (da) | Fremgangsmåde til fremstilling af D-ribose. | |
| DK134279B (da) | Analogifremgangsmåde til fremstilling af cycloalkylphenoxycarboxylsyrederivater. | |
| DK138796B (da) | Analogifremgangsmåde til fremstilling af 2-carboxypyrazin-4-oxidderivater. | |
| DK133977B (da) | Fremgangsmåde til fremstilling af 2-chlor-5-sulfamoylbenzoesyrer. | |
| DK135723B (da) | Analogifremgangsmåde til fremstilling af 7alfa-acylthio-3-oxo-D-homo-21,24-dinor-17aalfa-chlo-4-en-23,17a-lactoner. | |
| DK137577B (da) | Fremgangsmåde til fremstilling af zeaxanthin. | |
| DK131633B (da) | Fremgangsmåde til fremstilling af 3-(17beta-4-androsten-3-on-17beta-yl)-propiolacton. | |
| DK139716B (da) | Analogifremgangsmåde til fremstilling af 4-aminoamfetaminderivater. | |
| DK137043B (da) | Analogifremgangsmåde til fremstilling af nitrocarbostyrilforbindelser. | |
| DK135685B (da) | Analogifremgangsmåde til fremstilling af morfolinderivater. | |
| DK140411B (da) | Fremgangsmåde til fremstilling af deacetoxycephalosporin C. | |
| DK132328B (da) | Analogifremgangsmåde til fremstilling af 17beta-hydroxy-16,16-dimethylestr-4-en-3-on. | |
| DK135122B (da) | Analogifremgangsmåde til fremstilling af 4-aryl-5-aminoalkyl-4-oxazolin-2-onderivater. | |
| DK139682B (da) | Analogifremgangsmåde til fremstilling af eburnameninderivater. | |
| DK135943B (da) | Fremgangsmåde til fremstilling af propanolaminderivater. | |
| DK140670B (da) | Analogifremgangsmåde til fremstilling af ergopeptinderivater. | |
| DK136619B (da) | Fremgangsmåde til fremstilling af dihydrokanadensolid. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |